SGH
FRX

Sivik Global Healthcare’s FOREST LABORATORIES INC FRX Stock Holding History

Sivik Global Healthcare’s Portfolio FRX Stock Details FRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-26,100
Closed -$2.58M – 87
2014
Q2 		$2.58M Buy
26,100
+1,100
+4% +$103K 1.3% 35
2014
Q1 		$2.31M Sell
25,000
-25,000
-50% -$2.02M 1.44% 31
2013
Q4 		$3M Buy
+50,000
New +$2.52M 2.13% 18

Other funds holding FRX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
OFG
OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Sivik Global Healthcare's FRX Position: Q3 2014 in Review

Sivik Global Healthcare sold out of FOREST LABORATORIES INC (FRX) in Q3 2014, closing a stake of 26,100 shares — an estimated $2.58M sold.

Sivik Global Healthcare first reported a position in FRX in Q4 2013 and held it in 3 quarters. The position peaked at $3M in Q4 2013. 5 funds tracked by Wall St. Rank hold FRX as of Q3 2014.

  • Sivik Global Healthcare reported no remaining FOREST LABORATORIES INC position as of Q3 2014 after selling out during the quarter.
  • Sivik Global Healthcare sold 26,100 FOREST LABORATORIES INC shares in Q3 2014, an estimated $2.58M.
  • Sivik Global Healthcare first reported a position in FOREST LABORATORIES INC in Q4 2013 and held it in 3 quarters.
  • Sivik Global Healthcare's FOREST LABORATORIES INC position peaked at $3M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held FOREST LABORATORIES INC as of Q3 2014.

Based on Sivik Global Healthcare's 13F filing for Q3 2014, filed 3 Oct 2014.